Connect with us

Hi, what are you looking for?

Stock

US plans to reduce Intel’s $8.5 billion federal chips grant below $8 billion – New York Times

(Reuters) – The U.S. government plans to reduce Intel Corp (NASDAQ:INTC)’s preliminary $8.5 billion federal chips grant to less than $8 billion, the New York Times (NYSE:NYT) reported on Sunday citing unnamed sources.

The change took into account a $3 billion contract Intel had been offered to make chips for the Pentagon, the people told the Times.

This spring U.S. President Joe Biden’s administration said it was awarding Intel nearly $20 billion in grants and loans, supercharging the company’s domestic semiconductor chip output and marking the government’s largest outlay to subsidize leading-edge chip production.

The U.S. announced a preliminary agreement for $8.5 billion in grants and up to $11 billion in loans for Intel in Arizona, with some of the funding to be used to build two new factories and modernize an existing one.

The outlay was part of the 2022 CHIPS and Science Act, a bid to boost domestic semiconductor output with $52.7 billion in funding, including $39 billion in subsidies for semiconductor production and $11 billion for research and development.

This post appeared first on investing.com






    You May Also Like

    Editor's Pick

    Sen. JD Vance (R-Ohio) and Minnesota Gov. Tim Walz (D) will face off Tuesday night at a CBS News vice-presidential debate in New York....

    Economy

    A U.N. human rights group confirmed Hamas’ leader in Lebanon, who was recently killed by Israeli strikes, was their employee.  Fateh Sherif was killed...

    Latest News

    A North Korean defector who escaped to the South more than a decade ago was detained after attempting to cross back into North Korea...

    Investing

    Astron (ASX:ATR) and Energy Fuels (TSX:EFR,NYSEAMERICAN:UUUU) have completed the establishment of a joint venture to advance the Australia-based Donald rare earths and mineral sands...

    Disclaimer: balanceandcharge.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2024 balanceandcharge.com